Tus kws kho mob
QP35-20 Post Service COVID-19/Coronavirus Claim Appeals
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 25, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2751 - 2760 ntawm 4139
Tus kws kho mob
P24-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers - eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2020
Tus kws kho mob
2020 April Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2020
Tus kws kho mob
QP34-20 New Claims Status Online Messaging Available on Availity
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 25, 2020
Tus kws kho mob
QP33-20 Updates to Telemedicine/Telehealth and Telephone Call Reimbursement Policies
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 25, 2020
Tus kws kho mob
QP28-20 Updated Service Type Options for Surgery on Availity Portal
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 25, 2020
Tus kws kho mob
QP29-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Peanut Allergy
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 25, 2020
Tus kws kho mob
QP30-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 25, 2020
Tus kws kho mob
QP31-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 25, 2020
Tus kws kho mob
QP27-20 Coronavirus (COVID-19) Information for Providers
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 11, 2020